SCHEMBL6616433

SCHEMBL6616433

Cc1oc(-c2ccccc2)nc1CCOc1cccc2[nH]cc(C(C)C(=O)O)c12

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.54
PPARA Q07869 18/20 0.54
PPARD Q03181 6/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6618124 0.92 PPARG (0.50) PPARGPPARAPPARD
SCHEMBL6619532 0.82 PPARG (0.52) PPARGPPARAPPARD
SCHEMBL6616267 0.81 PPARG (0.51) PPARGPPARAPPARD
SCHEMBL6616076 0.80 KDM4E (0.51) PPARGPPARAPPARD
SCHEMBL6616213 0.80 PPARG (0.50) PPARGPPARAPPARD
SCHEMBL6614323 0.80 PPARG (0.52) PPARGPPARAPPARD
SCHEMBL6614426 0.78 PPARG (0.48) PPARGPPARAPPARD
SCHEMBL6581640 0.75 PPARG (0.70) PPARGPPARA
SCHEMBL6757661 0.73 PPARG (0.52) PPARGPPARAPPARD
SCHEMBL5758732 0.72 PPARG (0.60) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1423363-A1 ORAL ANTIDIABETIC AGENTS Warner-Lambert Company LLC (US) 2004-06-02 EP disclosed
WO-2003018553-A1 ORAL ANTIDIABETIC AGENTS WARNER-LAMBERT COMPANY LLC (US) 2003-03-06 WO disclosed